Wednesday, August 17, 2022


Multimedia News Content Leader in Washington since 1996

Contact FedNet to request video from this event

Contact FedNet to purchase a verbatim transcript

Emergent BioSolutions Vaccine

House Oversight and Reform Committee

Select Investigative Subcommittee on the Coronavirus Crisis

Examining Emergent BioSolutions’ Failure to Protect Public Health and Public Funds

Wednesday May 19, 2021 10:30 a.m.

Room: 2154 Rayburn Bldg.

Mr. Robert Kramer, President and Chief Executive Officer, Emergent BioSolutions

Mr. Fuad El-Hibri, Executive Chairman, Emergent